PT-141 (Bremelanotide, Melanocortin Receptor Agonist)
Melanocortin receptor agonist used in receptor-signaling research models.
Drag the vial to rotate the label
This compound is not currently available for purchase. Submit a request to help guide future inventory and testing priorities.
Melanocortin receptor agonist used in receptor-signaling research models.
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide analog of alpha-MSH that acts as a non-selective agonist at melanocortin receptors, with notable activity at MC3R and MC4R. Laboratory groups use it in receptor binding, cAMP accumulation, and β-arrestin recruitment assays to characterise melanocortin-family pharmacology in cultured cell lines. Supplied as a sterile lyophilized powder for reconstitution in bacteriostatic water. For laboratory research use only — not for human or veterinary use.
- Melanocortin MC3R / MC4R receptor binding assays
- cAMP second-messenger signaling studies
- Comparative melanocortin analog pharmacology
- Independently verified for identity and purity on a batch-specific basis.
- Certificates of analysis publicly accessible by lot ID — never averaged.
- Sourced through qualified manufacturing partners and shipped from the United States.
- Fast shipping, always tracked, shipped from the United States.
Research and documentation
Where this lot is in the release process
- 01
Backorder confirmed
Your product is reserved from the incoming lot.
- 02
Arriving for testing · ~6 days
Incoming lot is expected to reach our testing queue within 6 days.
- 03
Sample en route to lab
A representative sample is being sent for independent analytical testing.
- 04
Independent testing · 3–5 days
Identity, purity, and applicable analytical testing are completed.
- 05
Results verified
Results are reviewed and the certificate of analysis is published.
- 06
Ready to ship
Verified inventory is released and your order is prepared for shipment.
Timeframes are estimates. No certificate from another lot is substituted while testing is in progress.
